DuoWell A Plus Tablet 80/20/10/5 mg
Telmisartan 80mg · Rosuvastatin Calcium 20.8mg +2 more
Tablet · Prescription medication · Combination
Yuhan Corporation
MFDS item code 202202136 · Approved 2022.05.20
Treatment of hypertension and dyslipidemia (including hypercholesterolemia)
This medication is used for patients who suffer from both hypertension and dyslipidemia and need to take telmisartan/amlodipine combination and rosuvastatin/ezetimibe combination together. It is particularly helpful for patients with essential hypertension whose blood pressure control is not sufficient with either amlodipine or telmisartan alone. Additionally, it is effective in regulating cholesterol levels in patients with primary hypercholesterolemia or mixed dyslipidemia. This drug lowers total cholesterol, LDL cholesterol, Apo B, triglycerides, and non-HDL cholesterol while increasing HDL cholesterol, thereby improving blood lipid balance. When used in conjunction with a consistent dietary regimen, it contributes to effective management of the patient’s cardiovascular health. Therefore, this medication is used to assist in the regulation of blood pressure and lipid levels.
This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and the rosuvastatin/ezetimibe combination. The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Take this medicine whole; do not chew, split, or crush it. ○ Telmisartan/amlodipine The recommended dose of the telmisartan/amlodipine combination is once daily. It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before administering the telmisartan/amlodipine combination. However, if blood pressure is not controlled with the individual components, switching directly to the telmisartan/amlodipine combination may be considered as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or the telmisartan/amlodipine combination 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: In elderly patients aged 75 years and older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually. ○ Rosuvastatin/ezetimibe Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with the rosuvastatin/ezetimibe combination. The dose of the rosuvastatin/ezetimibe combination should be adjusted according to the patient's baseline LDL cholesterol level, the recommended treatment goal, and the patient's response. Primary hypercholesterolemia The dose range of the rosuvastatin/ezetimibe combination is 5/10mg–20/10mg once daily. The recommended initial dose is 5/10mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After initiating treatment with the rosuvastatin/ezetimibe combination or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased up to a maximum of 20/10mg once daily. Patients taking the telmisartan/amlodipine combination and the rosuvastatin/ezetimibe combination concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.
This medication may pose risks to the fetus, especially during pregnancy. Taking it during the second and third trimesters may cause serious harm such as hypotension, kidney problems, and impaired cranial formation in the fetus; therefore, it should be discontinued immediately upon confirmation of pregnancy. Patients at risk for muscle issues should exercise caution when using this medication. Symptoms such as myalgia or muscle weakness may occur, and in severe cases, rhabdomyolysis can develop; thus, immediate consultation with a doctor is necessary if symptoms arise. Patients with severely impaired liver or kidney function should not take this medication. For patients with mild liver or kidney function, careful consideration must be given to dosage adjustment or whether to take this medication. This medication should also not be given to patients who have allergies to specific ingredients, are lactose intolerant, have severe hypotension, or suffer from severe heart failure. Routine monitoring of blood pressure, liver function, kidney function, and blood potassium levels is required during the course of treatment, and any unusual symptoms must be reported to a doctor immediately. Additionally, this medication may interact with other drugs, so patients should inform their healthcare provider or pharmacist of any other medications they are taking. Caution is necessary as dizziness or drowsiness may occur while driving or operating machinery. Appropriate contraception is advised while taking this medication, and patients planning a pregnancy or currently pregnant should consult with healthcare professionals.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a sealed container. Additionally, it is important to keep it at a temperature between 1 to 30 degrees Celsius to maintain its effectiveness.
Pink oval film-coated tablet
30 tablets/box [6 tablets/PTP X 5]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Telmisartan 80mg · Rosuvastatin Calcium 20.8mg +2 more
Tablet · Prescription medication · Combination
Yuhan Corporation
Telmisartan 80mg · Rosuvastatin Calcium 5.2mg +2 more
Tablet · Prescription medication · Combination
Yuhan Corporation
Telmisartan 80mg · Rosuvastatin Calcium 10.4mg +2 more
Tablet · Prescription medication · Combination
Yuhan Corporation
Telmisartan 40mg · Rosuvastatin Calcium 5.2mg +2 more
Tablet · Prescription medication · Combination
Yuhan Corporation
Telmisartan 40mg · Rosuvastatin Calcium 20.8mg +2 more
Tablet · Prescription medication · Combination
Yuhan Corporation
Telmisartan 40mg · Rosuvastatin Calcium 10.4mg +2 more
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 40mg · Rosuvastatin Calcium 5.2mg +2 more
Tablet · Prescription medication · Combination
Green Cross Corporation
CombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg +2 more
Tablet · Prescription medication · Combination
Green Cross Corporation
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.